Zaid Fadul, MD, FS, FAAFP, introduces the Nolla Derm app, what it might mean for pharmacists and their patients, and where AI prescribing is headed in the future.
|Articles|December 10, 2007
Latebreakers: Final DEA rule OKs multiple Schedule II Rxs
A final rule from the DEA allows doctors to give patients multiple prescriptions for up to a 90-day supply of Schedule II controlled substances.
Advertisement
Advertisement
Related to this article
Among a collection of patients across 15 pharmacies, researchers assessed acceptability and satisfaction with pharmacist-led clinical services.
From expert sources and recent data updates to a look at cases amid the ongoing respiratory virus season, this is an updated look at 2026 measles outbreaks in the US.
Zaid Fadul, MD, FS, FAAFP, joins for part 2 to discuss what greater adoption of AI across health care ecosystems might mean for pharmacists, patients, and more.
For pharmacies competing with CVS and relying on Caremark to serve patients, the prospect of those businesses operating under separate ownership is significant.
Erin Albert of Mark Cuban Cost Plus Drugs explains how the Team Cuban Card offers transparent pricing and fair pay for independent pharmacies.
An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
Matthew Crawford, PhD, of the University of Virginia, and Mario Danek of Qnovia explain what pharmacists can do now and what may come next.
Advertisement
Advertisement
Trending on Drug Topics
1
Team Cuban Card Includes Transparent Pricing for Cash Patients
2
Measles Cases Near 5000 in 2026 as Flu Season Starts Earlier Than Usual
3
CVS Plans to Split Off Its Retail Pharmacies, Keeping Specialty Operations
4
An Inside Look at the First AI-Prescribing Technology
5